You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ad26.Mos.HIV

Showing 1 - 25 of 356
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Rwanda, United States (Ad26.Mos.HIV, Ad26.Mos4.HIV, Clade C gp140)

Completed
  • Healthy
  • Ad26.Mos.HIV
  • +3 more
  • Birmingham, Alabama
  • +9 more
Jul 5, 2022

Human Immunodeficiency Virus Trial in Bangkok (Ad26.Mos.HIV, MVA-Mosaic, Placebo)

Completed
Has Results
  • Human Immunodeficiency Virus
  • Ad26.Mos.HIV
  • +2 more
  • Bangkok, Thailand
    (unnamed)
Dec 29, 2021

Human Immunodeficiency Virus Trial in Boston (Ad26.Mos4.HIV, MVA-Mosaic, Clade C gp140 + Mosaic gp140)

Completed
  • Human Immunodeficiency Virus
  • Ad26.Mos4.HIV
  • +3 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Feb 7, 2022

HIV, AIDS, Immunologic Deficiency Syndrome, Acquired Trial in Boston (Ad26.Mos4.HIV, MVA-BN-HIV, PGT121)

Recruiting
  • HIV
  • +4 more
  • Ad26.Mos4.HIV
  • +4 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Apr 18, 2022

HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

Not yet recruiting
  • HIV-1-infection
  • VRC07-523LS
  • +7 more
  • Pathum Wan, Bangkok, Thailand
  • +1 more
Mar 8, 2023

HIV-1 Trial in Worldwide (Ad26.Mos4.HIV, Clade C gp140, Placebo)

Completed
  • HIV-1
  • Ad26.Mos4.HIV
  • +2 more
  • Lilongwe, Malawi
  • +22 more
Apr 12, 2022

Healthy Trial in Worldwide (Ad26.Mos4.HIV, Clade C and Mosaic gp140 HIV bivalent vaccine, Placebo)

Active, not recruiting
  • Healthy
  • Ad26.Mos4.HIV
  • +2 more
  • Birmingham, Alabama
  • +52 more
Jan 17, 2023

Coronavirus Disease-2019 (COVID-19) Prevention Trial in Worldwide (Ad26.COV2.S)

Active, not recruiting
  • Coronavirus Disease-2019 (COVID-19) Prevention
  • Ad26.COV2.S
  • Buenos Aires, Argentina
  • +17 more
Jan 17, 2023

Ebola Virus Disease, Ebola, Hiv Trial in Nairobi, Masaka (Ad26.ZEBOV)

Active, not recruiting
  • Ebola Virus Disease
  • +2 more
  • Ad26.ZEBOV
  • Nairobi, Kenya
  • +1 more
Nov 26, 2021

Hemorrhagic Fever, Ebola Trial in Worldwide (Ad26.ZEBOV, MVA-BN-Filo, Placebo)

Completed
Has Results
  • Hemorrhagic Fever, Ebola
  • Ad26.ZEBOV
  • +2 more
  • BoboDioulasso, Burkina Faso
  • +6 more
Feb 9, 2022

Healthy Trial in Boston (Ad26.Mos.HIV, Clade C gp140, Placebo)

Completed
  • Healthy
  • Ad26.Mos.HIV
  • +2 more
  • Boston, Massachusetts
    (unnamed)
Jan 22, 2019

COVID-19 Prevention Trial in Worldwide (Ad26.COV2.S)

Recruiting
  • COVID-19 Prevention
  • Ad26.COV2.S
  • Birmingham, Alabama
  • +48 more
Aug 2, 2022

SARS (Severe Acute Respiratory Syndrome) Trial in South Africa (To monitor the effectiveness of the single dose Ad26.COV2.S

Completed
  • SARS (Severe Acute Respiratory Syndrome)
  • To monitor the effectiveness of the single dose Ad26.COV2.S COVID-19 vaccine
  • Mthatha, Eastern Cape, South Africa
  • +30 more
Jul 29, 2022

COVID-19 Trial in South Africa (Ad26.COV2.S (VAC31518, JNJ-78436735) Vaccine, SARS-CoV-2 rS (CovovaxTM), BNT162b2 (Pfizer))

Recruiting
  • COVID-19
  • Ad26.COV2.S (VAC31518, JNJ-78436735) Vaccine, SARS-CoV-2 rS (CovovaxTM), BNT162b2 (Pfizer)
  • Pretoria, Gauteng, South Africa
  • +4 more
Aug 23, 2022

SARS CoV 2 Infection Trial in South Africa (Booster vaccine)

Recruiting
  • SARS CoV 2 Infection
  • Booster vaccine
  • Mthatha, Eastern Cape, South Africa
  • +30 more
Jul 29, 2022

Ebola Virus Disease Trial in Boende (Ad26.ZEBOV vaccine)

Completed
  • Ebola Virus Disease
  • Ad26.ZEBOV vaccine
  • Boende, Province De La Tshuapa, Congo, The Democratic Republic of the
    Hôpital Général de Référence de Boende
Jan 3, 2023

Hemorrhagic Fever, Ebola Trial in Worldwide (Ad26.ZEBOV, MVA-BN-Filo, Placebo)

Completed
Has Results
  • Hemorrhagic Fever, Ebola
  • Ad26.ZEBOV
  • +2 more
  • Silver Spring, Maryland
  • +6 more
Jan 27, 2022

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Not yet recruiting
  • Covid-19 Pandemics
  • Tuberculosis
  • Pfizer-BioNTech COVID-19 vaccine
  • +2 more
  • Mae Sot, Tak, Thailand
    Shoklo Malaria Research Unit (SMRU)
Oct 21, 2022

Coronavirus Disease Trial in United States (Ad26.COV2.S)

Completed
Has Results
  • Coronavirus Disease
  • Ad26.COV2.S
  • Phoenix, Arizona
  • +20 more
Jan 17, 2023

Respiratory Syncytial Virus Prevention Trial in United States (Ad26.RSV.PreF-based Vaccine)

Completed
  • Respiratory Syncytial Virus Prevention
  • Ad26.RSV.PreF-based Vaccine
  • Athens, Alabama
  • +12 more
Oct 25, 2022

Healthy Trial in Worldwide (Ad26.COV2.S, Placebo)

Completed
  • Healthy
  • Ad26.COV2.S
  • Placebo
  • Berlin, Germany
  • +12 more
May 3, 2022

Healthy Trial in Cuangugu, Gysenyi, Kigali (Ad26.ZEBOV, MVA-BN-Filo)

Active, not recruiting
  • Healthy
  • Ad26.ZEBOV
  • MVA-BN-Filo
  • Cuangugu, Rwanda
  • +2 more
Jan 17, 2023

Influenza, Human Prevention, Respiratory Syncytial Viruses Prevention Trial in United States (Ad26.RSV.preF-based vaccine,

Completed
  • Influenza, Human Prevention
  • Respiratory Syncytial Viruses Prevention
  • Ad26.RSV.preF-based vaccine
  • +2 more
  • Long Beach, California
  • +18 more
Oct 25, 2022

Ebola Virus Disease Trial in Kambia (Ad26.ZEBOV booster vaccination, given at a dose of 5x10^10 vp, via IM injection)

Active, not recruiting
  • Ebola Virus Disease
  • Ad26.ZEBOV booster vaccination, given at a dose of 5x10^10 vp, via IM injection
  • Kambia, Sierra Leone
    EBOVAC Kambia 1 clinic
Feb 25, 2022

COVID-19 Prevention Trial in Worldwide (Ad26.COV2.S)

Recruiting
  • COVID-19 Prevention
  • Ad26.COV2.S
  • Little Rock, Arkansas
  • +54 more
Aug 2, 2022